Tuesday, May 23, 2017 3:42:20 PM
The amount of time until the first human trial will begin, the number of years after that until FDA approval, and the amount of dilution that will be necessary after funds from the ipo are spent deserve some consideration, don't you think? Looks like they'll be starting out with 200 million shares outstanding.
Regarding any cash that may make its way to Marvin, when I mention him it also means his company. He has already made the statement that he would decide if and how shareholders might benefit from any success of Imagion. Now look at the last mhtx 10-Q and consider how far $6 million would go under the leadership of Manny and Marv. Another question - do you really believe Imagion will raise $12 million and give more than half of it to mhtx? Maybe that question is answered in the Imagion prospectus; have you seen it and, if so, is paying off the $6.9 million note listed there?
Recent MHTX News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 07:12:38 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 07:44:56 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/21/2023 08:04:24 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM